berbamine has been researched along with Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, X; Li, S; Ma, A; Wang, P; Wu, B; Wu, Z; Xu, R; Xu, Y; Yang, L; Yu, Q | 1 |
| Gu, Y; Ma, T; Qiu, X; Xie, J; Xu, R; Yu, Y; Zhang, L; Zhang, X | 1 |
| Han, YQ; Shi, YJ; Wu, SL; Yuan, JY; Zhu, Y | 1 |
3 other study(ies) available for berbamine and Leukemia
| Article | Year |
|---|---|
Novel synthetic tosyl chloride-berbamine regresses lethal MYC-positive leukemia by targeting CaMKIIγ/Myc axis.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Leukemic; Humans; Inhibitory Concentration 50; Leukemia; Mice; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; RNA, Messenger; Signal Transduction; Tosyl Compounds; Transcription, Genetic | 2019 |
Berbamine derivatives: a novel class of compounds for anti-leukemia activity.
Topics: Animals; Antineoplastic Agents; Benzamides; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Leukemia; Piperazines; Pyrimidines | 2009 |
[Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
Topics: Alkaloids; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Calmodulin; Cell Division; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Genes, MDR; Humans; Inhibitor of Apoptosis Proteins; K562 Cells; Leukemia; Microtubule-Associated Proteins; Neoplasm Proteins; RNA, Messenger; Survivin | 2003 |